IMR Press / CEOG / Special Issues / female_hyperandrogenism

Female Hyperandrogenism

Submission deadline: 30 June 2024
Special Issue Editors
  • Qian Zhong, MD
    Department of Obstetrics and Gynecology, West China Second University Hospital of Sichuan University, Chengdu, China
    Interests: female reproductive system; endocrinology; infertility; gynecologic laparoscopy
    Special Issues and Topics in IMR Press journals
    Special Issue in Endometriosis
  • Yi-Cheng Wu
    Department of Obstetrics and Gynecology, West China Second University Hospital of Sichuan University, Chengdu, China
    Interests: perinatology; maternal-fetal medicine; female life cycle support; high-risk pregnancy
Special Issue Information

Dear Colleagues,

Hyperandrogenism, characterized by an excess production of androgens, is a pervasive gynecologic endocrinology condition often associated with many health complications in women, such as polycystic ovary syndrome (PCOS), tumors, irregular menstrual cycles, and infertility. Although typical, this condition is complex and multifactorial, requiring a comprehensive understanding of effective clinical management.

Although there have been many studies investigating the hormonal, metabolic, and genetic aspects of hyperandrogenism, it remains a difficult condition to diagnose and manage. Additionally, symptoms of hyperandrogenism often appear before a definitive diagnosis can be made, highlighting the importance of reliable and non-invasive diagnostic biomarkers. While current treatment options can be helpful, their effectiveness varies and there is a significant risk of symptoms returning.

In our upcoming special issue on Female Hyperandrogenism, we will accept various articles, original research, short reports, letters, and reviews examining this condition from an interdisciplinary or multidisciplinary standpoint. Areas of interest encompass but are not limited to, diagnostic advancements, management of hormonal imbalances, innovative therapeutic approaches, and psycho-social implications of hyperandrogenism.

Hyperandrogenism within this realm holds potential for clinical benefits; we invite all submissions of manuscripts for peer review. We look forward to contributions that enrich our understanding and management of hyperandrogenism.

Dr. Qian Zhong and Dr. Yi-Cheng Wu
Guest Editors

polycystic ovary syndrome
female life cycle support
gynecologic tumor
female hirsutism
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.

Back to top